Kezar Life Sciences
50 hedge funds and large institutions have $176M invested in Kezar Life Sciences in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
50
Holders Change
+10
Holders Change %
+25%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
15
Increased
26
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BB
1
BB Biotech
Schaffhausen,
Switzerland
|
$21.7M |
2 |
2
BlackRock
New York
|
$11.3M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$7.2M |
4 |
SC
4
Slow Capital
Greenbrae,
California
|
$3.65M |
5 |
FM
5
Frazier Management
Seattle,
Washington
|
$6.57M |